All Stories

  1. Estimated incidence of disruptions to event-free survival from non-metastatic cancers in New South Wales, Australia - a population-wide epidemiological study of linked cancer registry and treatment data
  2. Innovative use of Australian cancer registry data for early detection of the effects of epidemics and other mass disruptions on cancer incidence
  3. Temporal trends in medication and service use patterns for mental health issues among men with prostate cancer
  4. Childhood Cancer Incidence and Survival in South Australia and the Northern Territory, 1990–2017, with Emphasis on Indigenous Peoples
  5. Impact of comorbidities on prostate cancer‐specific mortality: A population‐based cohort study
  6. Childhood Cancer Incidence and Survival in South Australia and the Northern Territory, 1990-2017, with Emphasis on Indigenous Peoples
  7. Warning labels for sugar-sweetened beverages and fruit juice: evaluation of 27 different labels on health effects, sugar content, energy and exercise equivalency
  8. Protocol for evaluating the fitness for purpose of an artificial intelligence product for radiology reporting in the BreastScreen New South Wales breast cancer screening programme
  9. Medication-based Comorbidity Measures and Prostate Cancer Treatment Selection
  10. Primary, allied health, selected specialists, and mental health service utilisation by home care recipients in Australia before and after accessing the care, 2017–2019
  11. Primary health care service utilisation before and after entry into long-term care in Australia
  12. Utility of prescription-based comorbidity indices for predicting mortality among Australian men with prostate cancer
  13. Mental Health Service Contact Following Cancer Diagnosis and Associations with Cancer Mortality: Results from a Linked Population-Based Study of Adolescents and Young Adults in New South Wales
  14. Prognostic value of comorbidity measures among Australian men with non-metastatic prostate cancer
  15. Risk of secondary malignancy following radiation therapy for prostate cancer
  16. Reporting Real-World Data on Prostate Cancer Treatment Outcomes to Consumers: The Prostate Cancer Report Card
  17. Demographic, health, and prognostic characteristics of Australians with liver cancer: a cohort study of linked data in New South Wales for informing cancer control
  18. The fraction of life years lost after diagnosis (FLYLAD): a person-centred measure of cancer burden
  19. REPCAN: Guideline for REporting Population-based CANcer Registry Data
  20. The effect of general practice contact on cancer stage at diagnosis in Aboriginal and non-Aboriginal residents of New South Wales
  21. Development of the consensus-based recommendations for Podiatry care of Neuropathy In Cancer Survivors (PodNICS): a Delphi consensus study of Australian podiatrists
  22. Variations in colorectal cancer pattern of care by age and comorbidity in South Australia
  23. Primary, allied health, geriatric, pain and palliative healthcare service utilisation by aged care residents, 2012–2017
  24. Associations of advanced age with comorbidity, stage and primary subsite as contributors to mortality from colorectal cancer
  25. Pregnancy‐associated gynecological cancer in New South Wales, Australia 1994–2013: A population‐based historical cohort study
  26. Increased Early Cancer Diagnosis: Unveiling Immune-Cancer Biology to Explain Clinical “Overdiagnosis”
  27. Pregnancy associated cancer, timing of birth and clinical decision making—a NSW data linkage study
  28. Long-term benefits for lower socioeconomic groups by improving bowel screening participation in South Australia: A modelling study
  29. “No Child or Adult Would Ever Probably Choose to Have 16 Teaspoons of Sugar”: A Preliminary Study of Parents’ Responses to Sugary Drink Warning Label Options
  30. Occurrence of comorbidity with colorectal cancer and variations by age and stage at diagnosis
  31. Second Primary Cancers Following Cancer Among Adolescents and Young Adults in Queensland, Australia, 1982–2018
  32. Multi-jurisdictional Prostate Cancer Registry Linkage.
  33. Interval cancers as related to frequency of recall to assessment in the South Australian population-based breast screening program: An exploratory study
  34. Impact of relational continuity of primary care in aged care: a systematic review
  35. “You can’t just eat 16 teaspoons of sugar so why would you drink 16 teaspoons’ worth of sugar?”: a qualitative study of young adults’ reactions to sugary drink warning labels
  36. The potential for tailored screening to reduce bowel cancer mortality for Aboriginal and Torres Strait Islander peoples in Australia: Modelling study
  37. Antibiotic exposure six months preceding systemic therapy was associated with lower cancer survival
  38. Body image and quality of life in women with breast cancer: Appreciating the body and its functionality
  39. Variations in utilisation of colorectal cancer services in South Australia indicated by MBS/PBS benefits: a benefit incidence analysis
  40. Changes in five‐year survival for people with acute leukaemia in South Australia, 1980–2016
  41. Warning labels and interpretive nutrition labels: Impact on substitution between sugar and artificially sweetened beverages, juice and water in a real-world selection task
  42. Challenges for ethics committees in biomedical research governance: Illustrations from China and Australia
  43. Factors involved in treatment decision making for women diagnosed with ductal carcinoma in situ: A qualitative study
  44. Associations between breast cancer screening participation and residential area sociodemographic features, geographic accessibility, and features of screening venue location in Greater Sydney, Australia
  45. Investigating the breast cancer screening–treatment–mortality pathway of women diagnosed with invasive breast cancer: Results from linked health data
  46. Prognostic Differences of RAS Mutations: Results from the South Australian Metastatic Colorectal Registry
  47. Regorafenib outcomes from the population based South Australian Metastatic Colorectal Cancer Registry
  48. Cancer Profiles, Times to Treatment, and Survival for Adolescents and Young Adults: Comparisons with Children and Older Adults in New South Wales, Australia
  49. Residential Area Sociodemographic and Breast Cancer Screening Venue Location Built Environmental Features Associated with Women’s Use of Closest Venue in Greater Sydney, Australia
  50. The premature mortality to incidence ratio (PREMIER): a person-centred measure of cancer burden
  51. Sharing Government Health Data With the Private Sector: Community Attitudes Survey
  52. Cohort profile: indigenous human papillomavirus and oropharyngeal squamous cell carcinoma study - a prospective longitudinal cohort
  53. Carcinosarcomas of the Uterus: Prognostic Factors and Impact of Adjuvant Treatment
  54. Overdiagnosis of screen‐detected breast cancer
  55. Residential area and screening venue location features associated with spatial variation in breast cancer screening invitation response rates: an observational study in Greater Sydney, Australia
  56. Degree of Cancer Spread at Presentation and Survival Among Adolescents and Young Adults in New South Wales, Australia
  57. Female breast cancer treatment and survival in South Australia: Results from linked health data
  58. Breast cancer treatment and survival differences in women in remote and socioeconomically disadvantaged areas, as demonstrated by linked data from New South Wales (NSW), Australia
  59. Female breast cancer in New South Wales, Australia, by country of birth: implications for health-service delivery
  60. Intentions to reduce sugar-sweetened beverage consumption: the importance of perceived susceptibility to health risks
  61. Measuring psychosocial outcomes of men living with prostate cancer: feasibility of regular assessment of patient‐reported outcomes
  62. Late mortality in people with cancer: a population‐based Australian study
  63. The Impact of Cancer on Early Childhood Development: A Linked Data Study
  64. A randomised online experimental study to compare responses to brief and extended surveys of health-related quality of life and psychosocial outcomes among women with breast cancer
  65. An In-Depth Exploration of Knowledge and Beliefs Associated with Soda and Diet Soda Consumption
  66. Sharing Government Health Data With the Private Sector: Community Attitudes Survey (Preprint)
  67. Young‐onset colorectal cancer is associated with a personal history of type 2 diabetes
  68. Optimal care pathways: A national policy to improve quality of cancer care and address inequalities in cancer outcomes
  69. Female breast cancer in New South Wales, Australia, by country of birth: implications for health-service delivery
  70. Metastasectomy and BRAF mutation; an analysis of survival outcome in metastatic colorectal cancer
  71. Cancers of the corpus uteri treated in South Australian public hospitals: Trends in clinical management and survival across three decades
  72. Engagement of General Practice in an Australian Organised Bowel Cancer Screening Program: A Cross-Sectional Survey of Knowledge and Practice
  73. Nothing beats taste or convenience: a national survey of where and why people buy sugary drinks in Australia
  74. Prevalence of Oral Human Papillomavirus Infection Among Australian Indigenous Adults
  75. Monitoring TNM stage of female breast cancer and survival across the South Australian population, with national and international TNM benchmarking: A population-based cohort study
  76. Consumption of Sugar-Sweetened Beverages, Juice, Artificially-Sweetened Soda and Bottled Water: An Australian Population Study
  77. Overdiagnosis of cancer in Australia: the role of screening
  78. History of screening by BreastScreen New South Wales of women with invasive breast cancer
  79. Treatment and outcomes of metastatic colorectal cancer patients in public and private hospitals: Results from the South Australian Metastatic Colorectal Cancer Registry
  80. Effect of mammography screening and sociodemographic factors on stage of female breast cancer at diagnosis in New South Wales
  81. Differences in breast cancer treatment pathways for women participating in screening through BreastScreen New South Wales
  82. Breast Cancer Incidence and Survival Among Young Females in Queensland, Australia
  83. Estimating the lifetime risks of cancer: the best measure depends on your purpose
  84. A population-based study of soft tissue sarcoma incidence and survival in Australia: An analysis of 26,970 cases
  85. Optimizing the measurement of comorbidity for a South Australian colorectal cancer population using administrative data
  86. Cancer treatment and the risk of cancer death among Aboriginal and non-Aboriginal South Australians: analysis of a matched cohort study
  87. Mix Design and Mechanical Properties of Rubberized Cement Stabilized Soil (RCSS) Pavers
  88. Time from diagnosis to treatment of colorectal cancer in a South Australian clinical registry cohort: how it varies and relates to survival
  89. Pre-diagnostic colonoscopies reduce cancer mortality - results from linked population-based data in South Australia
  90. Patterns of comorbidities in women with breast cancer: a Canadian population-based study
  91. The burden of cancer on primary and secondary health care services before and after cancer diagnosis in New South Wales, Australia
  92. Disparities in breast screening, stage at diagnosis, cancer treatment and the subsequent risk of cancer death: a retrospective, matched cohort of aboriginal and non-aboriginal women with breast cancer
  93. The effects of comorbidity on colorectal cancer mortality in an Australian cancer population
  94. Differences in cancer incidence by age at diagnosis between Aboriginal and non-Aboriginal people for cancer types included in Australian national screening programs
  95. Are Australians ready for warning labels, marketing bans and sugary drink taxes? Two cross-sectional surveys measuring support for policy responses to sugar-sweetened beverages
  96. “ When we were young, it really was a treat; now sugar is just the norm every day ” — A qualitative study of parents’ and young adults’ perceptions and consumption of sugary drinks
  97. Metastasectomy and BRAF mutation: An analysis of survival outcome in metastatic colorectal cancer.
  98. Type 2 diabetes as a potential risk marker for early onset colorectal cancer.
  99. Accounting for Immigrant Status when Calculating Cancer Incidence Rates for Bangkok
  100. Extent and predictors of grade upgrading and downgrading in an Australian cohort according to the new prostate cancer grade groupings
  101. Evaluation of an intervention to train health professionals working with Aboriginal and Torres Strait Islander people to provide smoking cessation advice
  102. Exploring the added value of hospital-registry data for showing local service outcomes: cancers of the ovary, fallopian tube and peritoneum
  103. Sugar-sweetened beverage (SSB) consumption, correlates and interventions among Australian Aboriginal and Torres Strait Islander communities: a scoping review
  104. Outcomes for Metastatic Colorectal Cancer Based on Microsatellite Instability: Results from the South Australian Metastatic Colorectal Cancer Registry
  105. Who drinks sugar sweetened beverages and juice? An Australian population study of behaviour, awareness and attitudes
  106. Patterns of health service utilisation among the Australian population with cancer compared with the general population
  107. The Use of Travel Time to Measure Geographic Accessibility to Breast Screening Services in New South Wales, Australia Short Paper
  108. Breast Screen Service Characteristics as a Measure of Accessibility
  109. Aboriginal women have a higher risk of cervical abnormalities at screening; South Australia, 1993–2016
  110. Developing a comorbidity index for comparing cancer outcomes in Aboriginal and non-Aboriginal Australians
  111. Using hospital registries in Australia to extend data availability on vulval cancer treatment and survival
  112. Has cancer survival improved for older people as for younger people? New South Wales, 1980–2012
  113. The survival outcome of patients with metastatic colorectal cancer based on the site of metastases and the impact of molecular markers and site of primary cancer on metastatic pattern
  114. Keratinocyte cancers in South Australia: incidence, geographical variability and service trends
  115. Human Papillomavirus and Oropharyngeal Cancer Among Indigenous Australians: Protocol for a Prevalence Study of Oral-Related Human Papillomavirus and Cost-Effectiveness of Prevention
  116. Changes in the prevalence of comorbidity in the Australian population with cancer, 2007–2014
  117. Australian Adolescents and Young Adults: Trends in Cancer Incidence, Mortality, and Survival Over Three Decades
  118. Do we know what to do with our nonagenarian and centenarian patients with metastatic colorectal cancer (mCRC)? Results from the South Australian mCRC registry
  119. Comorbidity and cervical cancer survival of Indigenous and non-Indigenous Australian women: A semi-national registry-based cohort study (2003-2012)
  120. Development of comorbidities in men with prostate cancer treated with androgen deprivation therapy: an Australian population-based cohort study
  121. Diabetes and smoking as predictors of cancer in Indigenous adults from rural and remote communities of North Queensland - A 15-year follow up study
  122. Comorbidities contribute to the risk of cancer death among Aboriginal and non-Aboriginal South Australians: Analysis of a matched cohort study
  123. Outcomes for metastatic colorectal cancer (mCRC) based on microsatellite instability.
  124. The impact of primary tumour resection and sidedness in patients with synchronous metastatic colorectal cancer (mCRC): Findings from the South Australian Metastatic Colorectal Cancer Registry (SAMCRC).
  125. Comorbidities in Australian women with hormone-dependent breast cancer: a population-based analysis
  126. Incidence of Comorbidities in Women with Breast Cancer Treated with Tamoxifen or an Aromatase Inhibitor: An Australian Population-Based Cohort Study
  127. Development of Indicators to Assess Quality of Care for Prostate Cancer
  128. Tools for Predicting Clinical and Patient-reported Outcomes in Prostate Cancer Patients Undergoing Androgen Deprivation Therapy: A Systematic Review of Prognostic Accuracy and Validity
  129. “Prostate cancer is far more hidden…”: Perceptions of stigma, social isolation and help-seeking among men with prostate cancer
  130. Barriers and facilitators for health professionals referring Aboriginal and Torres Strait Islander tobacco smokers to the Quitline
  131. Heart failure following blood cancer therapy in pediatric and adult populations
  132. Female breast cancer management and survival: The experience of major public hospitals in South Australia over 3 decades-trends by age and in the elderly
  133. Cancer epidemiology in the small nations of Pacific Islands
  134. Optimum Tools for Predicting Clinical Outcomes in Prostate Cancer Patients Undergoing Radical Prostatectomy: A Systematic Review of Prognostic Accuracy and Validity
  135. Human papillomavirus infection and intrauterine growth restriction: a data-linkage study
  136. Reply to ‘Comment on ‘Effect of population breast screening on breast cancer mortality up to 2005 in England and Wales: an individual-level cohort study’’
  137. The value of local registry data for describing cervical cancer management and outcomes over three decades in Australia
  138. Cancer survival disparities worsening by socio-economic disadvantage over the last 3 decades in new South Wales, Australia
  139. Bevacizumab first line and impact on subsequent anti-EGFR activity
  140. Sugar-sweetened beverage consumption, correlates and interventions among Australian Aboriginal and Torres Strait Islander communities: a scoping review protocol
  141. Tools for predicting patient-reported outcomes in prostate cancer patients undergoing radical prostatectomy: a systematic review of prognostic accuracy and validity
  142. After accounting for competing causes of death and more advanced stage, do Aboriginal and Torres Strait Islander peoples with cancer still have worse survival? A population-based cohort study in New South Wales
  143. Disparities in cancer stage at diagnosis and survival of Aboriginal and non-Aboriginal South Australians
  144. Does exclusion of cancers registered only from death-certificate information diminish socio-demographic disparities in recorded survival?
  145. Patient-Reported Outcomes After Radiation Therapy in Men With Prostate Cancer: A Systematic Review of Prognostic Tool Accuracy and Validity
  146. Bevacizumab and its impact on survival for patients receiving subsequent anti-EGFR therapy: Updated results from the SA metastatic CRC registry.
  147. The outcome of patients (pts) with metastatic colorectal cancer (mCRC) based on site of metastases (mets) and the impact of molecular markers and site of primary cancer on metastatic pattern.
  148. Australian validation of the Cancer of the Prostate Risk Assessment Post-Surgical score to predict biochemical recurrence after radical prostatectomy
  149. Use of guideline‐recommended adjuvant therapies and survival outcomes for people with colorectal cancer at tertiary referral hospitals in South Australia
  150. Findings in young adults at colonoscopy from a hospital service database audit
  151. Cancer survivorship monitoring systems for the collection of patient-reported outcomes: a systematic narrative review of international approaches
  152. PD47-11 OPTIMUM TOOLS FOR PREDICTING CLINICAL OUTCOMES IN PROSTATE CANCER PATIENTS UNDERGOING RADICAL PROSTATECTOMY: A SYSTEMATIC REVIEW OF PROGNOSTIC ACCURACY AND VALIDITY
  153. Comorbidity, physical and mental health among cancer patients and survivors: An Australian population-based study
  154. An appraisal of analytical tools used in predicting clinical outcomes following radiation therapy treatment of men with prostate cancer: a systematic review
  155. Assessing impact of organised breast screening across small residential areas-development and internal validation of a prediction model
  156. Variations in outcomes for Indigenous women with breast cancer in Australia: A systematic review
  157. Mammography service screening and breast cancer mortality in New Zealand: a National Cohort Study 1999–2011
  158. Time to clinical investigation for Indigenous and non-Indigenous Queensland women after a high grade abnormal Pap smear, 2000–2009
  159. Bevacizumab and its impact on survival for patients receiving subsequent anti-EGFR therapy: Results from the South Australian metastatic colorectal cancer registry.
  160. Nonagenarian patients with metastatic colorectal cancer: Results from the South Australian metastatic colorectal cancer registry.
  161. Patterns of care for synchronous rectal cancer with liver-only metastasis: Results from the South Australian registry of metastatic colorectal cancer.
  162. Administrative data provide vital research evidence for maximizing health-system performance and outcomes
  163. Pancreatectomy is underused in NSW regions with low institutional surgical volumes: a population data linkage study
  164. Cancer registration challenges in low- and middle-income countries-the case of the Pacific Islands
  165. History, development and future of cancer screening in Australia
  166. The impact of geographic unit of analysis on socioeconomic inequalities in cancer survival and distant summary stage – a population‐based study
  167. Cancer Data and Aboriginal Disparities (CanDAD)—developing an Advanced Cancer Data System for Aboriginal people in South Australia: a mixed methods research protocol
  168. High quality data are the key to understanding inequalities in cancer outcomes for Aboriginal and Torres Strait Islander Australians
  169. Heart failure following cancer treatment: characteristics, survival and mortality of a linked health data analysis
  170. Prevalence of Comorbidities and Health Status among Current Cancer and Cancer Survivors: An Australian Population-Based Study
  171. Brain metastasis in advanced colorectal cancer: Results from the South Australian metastatic colorectal cancer (SAmCRC) registry
  172. Breast cancer screening-opportunistic use of registry and linked screening data for local evaluation
  173. Prostate cancer outcomes for men who present with symptoms at diagnosis
  174. A retrospective analysis of Victorian and South Australian clinical registries for prostate cancer: trends in clinical presentation and management of the disease
  175. Short-term outcomes after surgical resection for colorectal cancer in South Australia
  176. Characteristics of patients with haematological and breast cancer (1996–2009) who died of heart failure‐related causes after cancer therapy
  177. Validation of administrative hospital data for identifying incident pancreatic and periampullary cancer cases: a population-based study using linked cancer registry and administrative hospital data in New South Wales, Australia
  178. Colorectal cancer treatment and survival over three decades at four major public hospitals in South Australia: trends by age and in the elderly
  179. Is Survival for Patients with Resectable Lung Metastatic Colorectal Cancer Comparable to Those with Resectable Liver Disease? Results from the South Australian Metastatic Colorectal Registry
  180. The first comprehensive report on Indigenous Australian women's inequalities in cervical screening: A retrospective registry cohort study in Queensland, Australia (2000‐2011)
  181. Cervical Abnormalities Are More Common among Indigenous than Other Australian Women: A Retrospective Record-Linkage Study, 2000–2011
  182. Differences in impact of Aboriginal and Torres Strait Islander status on cancer stage and survival by level of socio-economic disadvantage and remoteness of residence—A population-based cohort study in Australia
  183. The utility of linked cancer registry and health administration data for describing system-wide outcomes and research: a BreastScreen example
  184. Metastatic Colorectal Cancer in Young Adults: A Study From the South Australian Population-Based Registry
  185. Cancer Data and Aboriginal Disparities Project (CanDAD) - an overdue cancer control initiative
  186. Development of an International Prostate Cancer Outcomes Registry
  187. Survival improvements associated with access to biological agents: Results from the South Australian (SA) metastatic colorectal cancer (mCRC) registry
  188. Socio-demographic disadvantage and distant summary stage of cancer at diagnosis—A population-based study in New South Wales
  189. Development of South Australian-Victorian Prostate Cancer Health Outcomes Research Dataset
  190. Recent advances of sonodynamic therapy in cancer treatment
  191. BRAF Mutation Testing and Metastatic Colorectal Cancer in the Community Setting: Is There an Urgent Need for More Education?
  192. Sociodemographic disparities in survival from colorectal cancer in South Australia: a population-wide data linkage study
  193. Metastatic Colorectal Cancer Treatment and Survival: the Experience of Major Public Hospitals in South Australia Over Three Decades
  194. 2163 BRAF testing in the community setting; are we testing enough given the importance of BRAF mutation and the clinical implications?
  195. Comparable survival outcome of metastatic colorectal cancer in Indigenous and non-Indigenous patients: Retrospective analysis of the South Australian metastatic colorectal cancer registry
  196. Death Analysis of a Cohort of Blood, Lymphatic Cancer and Breast Cancer Patients Who Have Developed Heart Failure Following Cancer Treatment
  197. Risk profile of breast cancer following atypical hyperplasia detected through organized screening
  198. Abstracts of poster presentations
  199. Survival impact of primary tumor resection in patients (pts) with unresectable metastatic colorectal cancer (mCRC): Findings from the South Australian Metastatic Colorectal Cancer Registry (SAMCRC).
  200. Estimates of over-diagnosis of breast cancer due to population-based mammography screening in South Australia after adjustment for lead time effects
  201. Breast Cancer Characteristics and Survival Differences between Maori, Pacific and other New Zealand Women Included in the Quality Audit Program of Breast Surgeons of Australia and New Zealand
  202. Colorectal Cancer Treatment and Survival: the Experience of Major Public Hospitals in South Australia over three Decades
  203. Translation from clinical trials to routine practice: How to demonstrate community benefit
  204. Performance Indices of Needle Biopsy Procedures for the Assessment of Screen Detected Abnormalities in Services Accredited by BreastScreen Australia
  205. Survival for patients with resectable lung metastatic colorectal cancer (mCRC).
  206. Changing roles of population-based cancer registries in Australia
  207. Rising incidence of early-onset colorectal cancer in Australia over two decades: Report and review
  208. A qualitative investigation of knowledge, beliefs and attitudes regarding sugar-sweetened beverages, including responses to potential regulatory measures aimed at curbing obesity
  209. Estimating over-diagnosis of breast cancer (Authors' Reply)
  210. Does the primary site of colorectal cancer impact outcomes for patients with metastatic disease?
  211. Colorectal cancer screening and subsequent incidence of colorectal cancer: results from the 45 and Up Study
  212. Monitoring approval of new legislation banning smoking in children's playgrounds and public transport stops in South Australia: Table 1
  213. Equivalence of outcomes for rural and metropolitan patients with metastatic colorectal cancer in South Australia
  214. What factors are predictive of surgical resection and survival from localised non-small cell lung cancer?
  215. Breast cancer survival in New Zealand women
  216. Realising opportunities for evidence-based cancer service delivery and research: linking cancer registry and administrative data in Australia
  217. Does Exact Primary Site Impact on Outcome for Metastatic Colorectal Cancer (Mcrc)?
  218. A novel case-control design to estimate the extent of over-diagnosis of breast cancer due to organised population-based mammography screening
  219. Development and Validation of a Risk Score Predicting Risk of Colorectal Cancer
  220. Cardiotoxicity following Cancer Treatment: Linked Health Data Analysis
  221. Influence of Service Characteristics on High Priority Performance Indicators and Standards in the BreastScreen Australia Program
  222. Colorectal Cancer Survival: An Analysis of Patients With Metastatic Disease Synchronous and Metachronous With the Primary Tumor
  223. Treatment patterns among colorectal cancer patients in South Australia: a demonstration of the utility of population-based data linkage
  224. Patterns of care and outcomes for young patients (age < 40) with metastatic colorectal cancer (mCRC): Findings from a population-based registry.
  225. Survival improvements associated with access to biologic agents: Results from the South Australian (SA) Metastatic Colorectal (mCRC) Registry.
  226. Survival outcomes for patients with metastatic colorectal cancer (mCRC) based on primary site, right (R) colon versus left (L) colon versus rectal (Rec) primary: Results from the South Australian Registry of mCRC.
  227. Influence of Mammographic Screening on Breast Cancer Incidence Trends in South Australia
  228. What Roles should Population-based Cancer Registries be Playing in the 21st Century? Reflections on the Asian Cancer Registry Forum, Bangkok, February 2014
  229. Trends in migrant mortality rates in Australia 1981–2007: a focus on the National Health Priority Areas other than cancer
  230. A systematic review of surgical biopsy for LCIS found at core needle biopsy – Do we have the answer yet?
  231. Cancer survival for Aboriginal and Torres Strait Islander Australians: a national study of survival rates and excess mortality
  232. Right (R) or left (L) primary site of colorectal cancer and outcomes for metastatic colorectal cancer (mCRC): Results from the south Australian registry of mCRC.
  233. Analysing risk factors for poorer breast cancer outcomes in residents of lower socioeconomic areas of Australia
  234. The La antigen is over-expressed in lung cancer and is a selective dead cancer cell target for radioimmunotherapy using the La-specific antibody APOMAB®
  235. Factors predictive of immediate breast reconstruction following mastectomy for invasive breast cancer in Australia
  236. Do breast cancer risk factors differ among those who do and do not undertake mammography screening?
  237. Can cancer registries show whether treatment is contributing to survival increases for melanoma of the skin at a population level?
  238. Do metastatic colorectal cancer patients who present with late relapse after curative surgery have a better survival?
  239. Impact of hormone replacement therapy use on mammographic screening outcomes
  240. Factors Predictive of Treatment by Australian Breast Surgeons of Invasive Female Breast Cancer by Mastectomy rather than Breast Conserving Surgery
  241. Risk Factors for Poorer Breast Cancer Outcomes in Residents of Remote Areas of Australia
  242. A population-based study of metastatic colorectal cancer in individuals aged ≥80 years
  243. Estimating prevalence of distant metastatic breast cancer: a means of filling a data gap
  244. Age effects on survival from early breast cancer in clinical settings in Australia
  245. Incidence of metastatic breast cancer in an Australian population-based cohort of women with non-metastatic breast cancer at diagnosis
  246. Impact of age on choice of chemotherapy and outcome in advanced colorectal cancer
  247. Adherence to Recommended Treatments for Early Invasive Breast Cancer: Decisions of Women Attending Surgeons in the Breast Cancer Audit of Australia and New Zealand
  248. Survival From Synchronous Bilateral Breast Cancer: The Experience of Surgeons Participating in the Breast Audit of the Society of Breast Surgeons of Australia and New Zealand
  249. Trends in cancer mortality rates among migrants in Australia: 1981–2007
  250. A review of community engagement in cancer control studies among Indigenous people of Australia, New Zealand, Canada and the USA
  251. Mammography screening and breast cancer mortality in Australia: an aggregate cohort study
  252. Breast Screening and Breast Cancer Survival in Aboriginal and Torres Strait Islander Women of Australia
  253. Survival from breast cancer: an analysis of Australian data by surgeon case load, treatment centre location, and health insurance status
  254. What factors affect the odds of NSW cancer patients presenting with localised as opposed to more advanced cancer?
  255. Estimating cancer incidence in Indigenous Australians
  256. Small Cell Lung Cancer: Patterns of care and their influence on survival - 25 years experience of a single Australian oncology unit
  257. An analysis of the effect of stage at diagnosis of bowel cancer on survival: Findings from the South Australian Clinical Registry (SACR) for metastatic colorectal cancer (mCRC).
  258. Impact of watching prior to commencement of chemotherapy for metastatic colorectal cancer (mCRC): Findings from the South Australian Clinical Registry (SACR) for mCRC.
  259. Clinical characteristics and outcomes of bilateral breast cancer in an Australian cohort
  260. A population-based study of metastatic colorectal cancer (mCRC) in people age 80 and older: Findings from the South Australian Clinical Registry (SACR) for mCRC.
  261. Do the benefits of screening mammography outweigh the harms of overdiagnosis and unnecessary treatment? - Yes
  262. Outcomes of lymphoma in South Australia, 1977-2007
  263. South Australian clinical registry for metastatic colorectal cancer
  264. Survival from breast cancers managed by surgeons participating in the National Breast Cancer Audit of the Royal Australasian College of Surgeons
  265. Variation in the management of early breast cancer in rural and metropolitan centres: Implications for the organisation of rural cancer services
  266. Epidemiology of neuroendocrine cancers in an Australian population
  267. Review Paper: The Health Status of Migrants in Australia: A Review
  268. PROPOSALS FOR EPIDEMIOLOGICAL SURVEILLANCE OF OCCUPATIONAL HEALTH IN AUSTRALIA
  269. IMMUNIZATION STATUS OF SOUTH AUSTRALIAN CHILDREN BY SOCIOECONOMIC STATUS AND ETHNICITY
  270. MONITORING CASE SURVIVAL BY HISTOLOGICAL TYPE FOR LUNG CANCER, BREAST CANCER AND NON-HODGKIN'S LYMPHOMAS - ONE FUNCTION OF A POPULATION-BASED REGISTRY
  271. A PERSPECTIVE OF THE CANCER PROBLEM IN SOUTH AUSTRALIA
  272. Patterns of Surgical Treatment for Women with Breast Cancer in Relation to Age
  273. Clinical and socio-demographic profile of an Australian multi-institutional prostate cancer cohort
  274. Bladder cancer survivals in New South Wales, Australia: why do women have poorer survival than men?
  275. Variations in care for operable breast cancer and outcomes between rural and metropolitan centers in Australia
  276. Exploring contrary trends in bladder cancer incidence, mortality and survival: implications for research and cancer control
  277. Reasons for Improved Survival From Ovarian Cancer in New South Wales, Australia, Between 1980 and 2003
  278. Patient and carer perceptions of cancer care in South Australia
  279. Management and Survival Trends in Advanced Colorectal Cancer
  280. Exploring the epidemiological characteristics of cancers of unknown primary site in an Australian population: implications for research and clinical care
  281. TRENDS IN SURGICAL TREATMENT OF YOUNGER PATIENTS WITH BREAST CANCER IN AUSTRALIA AND NEW ZEALAND
  282. Survival and degree of spread for female breast cancers in New South Wales from 1980 to 2003: implications for cancer control
  283. COMMENTARY: HOW SURGICAL AUDITS CAN BE USED TO PROMOTE THE UPDATE OF SURGICAL EVIDENCE
  284. A case–control study of the protective benefit of cervical screening against invasive cervical cancer in NSW women
  285. Prognosis of sub-types of cancer of unknown primary (CUP) compared to metastatic cancer
  286. Population screening and intensity of screening are associated with reduced breast cancer mortality: evidence of efficacy of mammography screening in Australia
  287. Benchmarking epidemiological characteristics of cervical cancer in advance of change in screening practice and commencement of vaccination
  288. Treatment and survival from breast cancer: the experience of patients at South Australian teaching hospitals between 1977 and 2003
  289. Endometrial cells as a predictor of uterine cancer
  290. A cost-effectiveness analysis of adding a human papillomavirus vaccine to the Australian National Cervical Cancer Screening Program
  291. Clinical and pathological factors predictive of lymph node status in women with screen-detected breast cancer
  292. Tobacco and alcohol-related mortality in men: estimates from the Australian cohort of petroleum industry workers
  293. Survival trends for advanced colorectal cancer (CRC): Are improvements only for patients in clinical trials?
  294. Prognostic importance of palpability as a feature of screen-detected breast cancers
  295. Factors predictive of preferred place of death in the general population of South Australia
  296. Update of mortality and cancer incidence in the Australian petroleum industry cohort
  297. Asbestos-Related Cancers in Refinery Workers in the Australian Petroleum Industry
  298. Treatment and Survival from Colorectal Cancer: The Experience of Patients at South Australian Teaching Hospitals Between 1980 and 2002
  299. Multiple primary cancers of separate organ sites: implications for research and cancer control (Australia)
  300. Does emotional support influence survival? Findings from a longitudinal study of patients with advanced cancer
  301. Female breast cancers are getting smaller, but socio-demographic differences remain
  302. Detection by screening mammography is a powerful independent predictor of survival in women diagnosed with breast cancer
  303. Time trends in lung cancer incidence by histology in South Australia: likely causes and public health implications
  304. A critical analysis of reasons for improved survival from invasive cutaneous melanoma
  305. Effects of variations in hysterectomy status on population coverage by cervical screening
  306. Risk of cancer in patients with scleroderma: a population based cohort study
  307. Use of radiotherapy in the primary treatment of cancer in South Australia
  308. Cervical cancer: effect of glandular cell type on prognosis, treatment, and survival
  309. The epidemiology of gastric cancer
  310. Issues of consent and privacy affecting the functioning of ASERNIP-S
  311. The coverage of cancer patients by designated palliative services: a population-based study, South Australia, 1999
  312. Tumour location and prognostic characteristics as determinants of survival of women with invasive breast cancer: South Australian hospital-based cancer registries, 1987–1998
  313. An analysis of factors associated with interval as opposed to screen-detected breast cancers, including hormone therapy and mammographic density
  314. LIP CANCER IN SOUTH AUSTRALIA, 1977–1996
  315. Lip cancer in South Australia, 1977–1996
  316. Somatic mutations, acetylator status, and prognosis in colorectal cancer
  317. Rehospitalisation for asthma within 12 months: unequal rates on the basis of gender at two hospitals
  318. Trends in perinatal characteristics in South Australia, 1981 to 1994, by place of residence of mother
  319. Near-fatal asthma in South Australia:descriptive features and medication use
  320. Perinatal mortality trends among South Australian Aboriginal births 1981–92
  321. Characteristics of near-fatal asthma in childhood
  322. Medroxyprogesterone acetate therapy in advanced breast cancer: the predictive value of androgen receptor expression.
  323. Trends in prostate cancer incidence and mortality rates in South Australia, 1977‐1993
  324. Brain cancer incidence, mortality and case survival: Observations from two australian cancer registries
  325. Near fatal asthma attacks: the reliability of descriptive information collected from close acquaintances.
  326. Evaluation of the lead Decontamination programme in the leading smelting town of port Pirie (South Australia)
  327. Trends in the terminal care of cancer patients: South Australia, 1981-1990
  328. Birthweight‐Specific Trends in Perinatal Mortality by Hospital Category in South Australia, 1985–1990
  329. Breech Presentation in South Australia, 1987–1989
  330. The association of low socio-economic status in metropolitan adelaide with maternal demographic and obstetric characteristics and pregnancy outcome
  331. Factors Predictive of Corneal Graft Survival
  332. The Association of Maternal and Socioeconomic Characteristics in Metropolitan Adelaide with Medical, Obstetric and Labour Complications and Pregnancy Outcomes
  333. The South Australian Cancer Registry: a means of assessing cancer incidence, mortality and case survival
  334. Increased age and mortality associated with cervical carcinomas negative for human papillomavirus RNA
  335. Radon daughter exposures at the Radium Hill uranium mine and lung cancer rates among former workers, 1952?87
  336. Case‐survival rates for infiltrating ductal carcinomas by category of hospital at diagnosis in South Australia
  337. Epidemiological characteristics of Legionella infection in South Australia: implications for disease control
  338. Malignant astrocytoma in South Australia: treatment and case survival
  339. Pregnancy and perinatal factors associated with persistently low apgar scores: An analysis of the birth records of infants born in South Australia
  340. Actuarial predictions from population‐based disease registries with unidentified random losses
  341. Infiltrating ductal carcinoma of the breast in South Australia
  342. Epidemiological features of melanoma in South Australia: implications for cancer control (for editorial comment, see page 490)
  343. Pregnancy and birth risk factors for intellectual disability in South Australia
  344. Cervical Cancer in South Australia: Trends in Incidence, Mortality and Case Survival
  345. The use of State and hospital‐based cancer‐registry data to describe the epidemiological and clinical characteristics of laryngeal cancer in South Australia
  346. Cancer case‐survival rates for South Australia: a comparison with US rates and a preliminary investigation of time trends
  347. Obstetric Profiles of Immigrant Women from Non-English Speaking Countries in South Australia, 1981–1983
  348. Professionally defined dental treatment needs of middle-aged and older patients attending 21 general practitioners, as related to tooth retention
  349. Determinants of the microbiological characteristics of spa pools in South Australia
  350. The dental health and treatment needs of middle-aged and older patients attending 21 general dental practitioners in South Australia
  351. Children's Blood Lead Levels in the Lead Smelting Town of Port Pirie, South Australia
  352. Melanoma case survival rates in South Australia by histological type, thickness and level of tumour at diagnosis
  353. Blood lead levels in children in the north‐west of Adelaide
  354. A Nine Year Retrospective Mortality Study of Workers in a British Pharmaceutical Company
  355. Increased tolerance to complete dentures after surgical modification of mylohyoid ridges
  356. Mortality from influenza and allied infections in South Australia during 1968‐1981
  357. Promotion of breast self‐examination in South Australia: A short‐term evaluation
  358. Determinants of case survival for cancers of the lung, colon, breast and cervix in South Australia
  359. Epidemiological surveillance of occupational health in Australia
  360. The association of naegleria fowleri with the chemical, microbiological and physical characteristics of South Australian water supplies
  361. Oral cancer in South Australia-incidence and case survival
  362. A Comparison of Australian Suicide Rates in 1969–73 and 1976–80
  363. Infiltrating ductal carcinoma of the breast in South Australia Sizes of primary lesions and histological evidence of axillary nodal metastases
  364. Byssinosis: A Cross-Sectional Study in an Australian Textile Factory
  365. Population‐based comparative study of campylobacter and salmonella enteritis in South Australia
  366. Survival of South Australian cancer patients
  367. Fluoridation II: An interim economic analysis
  368. The dental health status of children not included by parents in the South Australian School Dental Programme. A pilot study
  369. DENTAL HEALTH EDUCATION
  370. Fluoridation 1. Effects on children's caries rates and professionally defined requirements for dental care
  371. Assessing the effectiveness of dental health education in the South Australian School Dental Programme
  372. Saliva-based colorimetric test as an index of gingival inflammation in epidemiologic studies
  373. THE EMPLOYMENT OF DENTAL NURSES
  374. EVALUATION OF DENTAL HEALTH EDUCATION IN A SCHOOL DENTAL CARE PROGRAM
  375. The effect of a pilot dental health education programme on high school students
  376. The sealing of fissures in a school dental programme
  377. The effect of treatment provided by dentists and therapists in the South Australian school dental service. The second report
  378. Tooth loss in South Australia
  379. The treatment of first permanent molars in a school dental programme: Implications for fissure sealants
  380. Tooth loss, the wearing of dentures and the demand for dental care in the south-east of South Australia
  381. Diagnosis, treatment planning and referral by school dental therapists
  382. The effect of treatment provided by dentists and therapists in the South Australian School Dental Service
  383. The association between dental caries and the availability of sweets in South Australian school canteens
  384. THE SCHOOL DENTAL THERAPIST OF SOUTH AUSTRALIA
  385. The dental health of South Australian country children
  386. The dental health and habits of South Australian children from different socio-economic environments
  387. The South Australian school canteen programme: An interim report
  388. A study of dental knowledge and behaviour in 1,000 Australian schoolchildren